Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
35.93
-0.31 (-0.86%)
At close: Jul 11, 2025, 4:00 PM
37.27
+1.34 (3.72%)
After-hours: Jul 11, 2025, 7:50 PM EDT
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $4.64 billion as of July 11, 2025. Its market cap has decreased by -43.78% in one year.
Market Cap
4.64B
Enterprise Value
3.05B
1-Year Change
-43.78%
Ranking
Category
Stock Price
$35.93
Market Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $4.64B, an increase of 235.89%. That is a compound annual growth rate of 26.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2025 | 4.68B | -54.18% |
| Dec 31, 2024 | 10.20B | 70.74% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.58% |
| Dec 31, 2021 | 1.26B | -7.24% |
| Dec 31, 2020 | 1.35B | -1.90% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 709.79B |
| Johnson & Johnson | 379.41B |
| AbbVie | 344.45B |
| Novo Nordisk | 316.64B |
| UnitedHealth Group | 271.70B |
| Novartis AG | 243.81B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 223.49B |